Description
Deliver Comprehensive Cell Protection
- GSH is involved in regulating cancer cell death, including necrosis and autophagy.
- Glutathione offers protection against side effects of both radiation and chemotherapy
- Significantly reduces nephrotoxicity and offer greater tumor response in patients with ovarian cancer.
- Improves quality of life, allowing more cycles of chemotherapy.
- Prevent cellular damage caused by free radicals and peroxides.
Reviews (0)
You must be logged in to post a review.
Related products
Glutaserv
Information about Glutaserv 250mg Soft Gelatin Capsule
- Glutaserv 250mg Soft Gelatin Capsule contains Glutathione which helps in fortify immune system , reduces melanin production and as an essential antioxidant, assisting the body in protecting cells from free radical damage.
Key Ingredients:
- Reduced Glutathione 250mg
Glutaserv-600
Prevent chemotherapy and radiotherapy induced toxicity
Key Ingredients:
Glutathione 600 mg injections- Effective for the prevention of platins and taxanes induced neuropathy
- Dose not reduce the clinical activity of chemotherapic drugs
- Protect the body from oxidative damage
- Regulate programmed cancer cell death (apoptosis)
- Counteract the prolonged antipyrine metabolism in alcoholic cirrhotic patients
- Improve hepatic functions
- Effective for alcoholic and non- alcoholic liver disorders
- Enhances insulin secretion in people with impaired glucose tolerance
Proserv Protein Powder
Key Ingredients:
High Protein with EPA Proserv- High level of high-quality protein to help build muscle mass.
- Boost immunity reduces toxic effects of chemotherapy.
- Prevent cell mutation reduces myelotoxicity.
- Energy-dense formulation, with 300 calories in each serving to provide energy in a small volume
- Contains EPA and Omega 3 Fatty Acid to help normalize metabolism, and provides additional calories and protein to help you regain weight and muscle mass.
- Enhances levels of vitamins and minerals that are commonly reduced in cancer patients
Reviews
There are no reviews yet.